NICE approves idelalisib (Zydelig®) for the tr... - CLL Support
NICE approves idelalisib (Zydelig®) for the treatment of chronic lymphocytic leukaemia in England and Wales
You need to be a member of this community to see this post.
Read more about...
16 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
UK NICE Approves Ibrutinib +Venetoclax for First Line treatment for ALL Patients from today
this effective treatment is now available for ALL CLL patients as their first treatment if their...
Interesting recently published overview of Chronic Lymphocytic Leukaemia and Hairy-Cell Leukaemia
Chronic Lymphocytic Leukaemia and Hairy-Cell Leukaemia
October 15, 2013 | Cancer Management
By...
Leukaemia Care Updated Patient Information - Richter's Syndrome in Chronic Lymphocytic Leukaemia
uk/wp-content/uploads/Richter-Syndrome-in-Chronic-Lymphocytic-Leukaemia-CLL-Web-Version.pdf
Jackie...
Health Canada approves Ibrutinib plus Rituximab for First Line Treatment of Patients with Chronic Lymphocytic Leukemia (CLL)
newswire.ca/news-releases/health-canada-approves-imbruvica-r-ibrutinib-plus-rituximab-for-the-treatm
new NICE approved CLL treatment zanubrutinib TA931
You've probably already heard about this NICE recommended treatment - as always the devil is in...
Related Posts
Revolution of Chronic Lymphocytic LeukemiaTherapy: the Chemo-Free Treatment Paradigm
Chemo-Free Treatment Best Option for CLL Patients Under 70
Can anyone confirm if Ibrutinib is now available on prescription in the UK?
Canadian Study...treatment increases risk of secondary cancers in CLL
Ibrutinib Slow but steady foreward movement.
